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Abstract
Chronic wounds are a significant socioeconomic problem for governments worldwide. Approximately 15% of people who
suffer from diabetes will experience a lower-limb ulcer at some stage of their lives, and 24% of these wounds will ultimately
result in amputation of the lower limb. Hyperbaric Oxygen Therapy (HBOT) has been shown to aid the healing of chronic
wounds; however, the causal reasons for the improved healing remain unclear and hence current HBOT protocols remain
empirical. Here we develop a three-species mathematical model of wound healing that is used to simulate the application
of hyperbaric oxygen therapy in the treatment of wounds. Based on our modelling, we predict that intermittent HBOT will
assist chronic wound healing while normobaric oxygen is ineffective in treating such wounds. Furthermore, treatment
should continue until healing is complete, and HBOT will not stimulate healing under all circumstances, leading us to
conclude that finding the right protocol for an individual patient is crucial if HBOT is to be effective. We provide constraints
that depend on the model parameters for the range of HBOT protocols that will stimulate healing. More specifically, we
predict that patients with a poor arterial supply of oxygen, high consumption of oxygen by the wound tissue, chronically
hypoxic wounds, and/or a dysfunctional endothelial cell response to oxygen are at risk of nonresponsiveness to HBOT. The
work of this paper can, in some way, highlight which patients are most likely to respond well to HBOT (for example, those
with a good arterial supply), and thus has the potential to assist in improving both the success rate and hence the cost-
effectiveness of this therapy.
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Introduction
Chronic leg ulceration is a significant socioeconomic problem
[1]. Those who suffer from leg ulcers experience considerable
pain, immobility and decreased quality of life [2]. Approximately
3% of the over 60 age group suffer from lower limb ulceration [3].
A successfully healing wound (or an ‘‘acute’’ wound) is typically
thought to progress through four stages; haemostasis, inflammation,
proliferation and remodelling [4,5], although these processes are
interconnected and overlapping. Haemostasis should last a matter of
hours during which time the blood flow is stopped. Inflammation sees
the production of chemoattractants that stimulate fibroblasts, the
dominant cell in the proliferative stage of healing, to migrate into the
wound site and to produce collagen, the main component of the
extracellular matrix (ECM). The cocktail of chemoattractants also
stimulatethesystematicrearrangementofendothelialcells(ECs)from
neighbouring blood vessels [6]. Capillary sprout extension is
facilitated by EC proliferation and further migration toward the
chemical attractant. The joining of two capillary sprouts within a
healing wound forms a loop through which blood can flow and new
sprouts develop from this vessel thus propagating angiogenesis [7].
A chronic wound is one in which healing fails to proceed
through an orderly and timely process to produce anatomic and
functional integrity, or proceeds through the repair process
without establishing a sustained anatomic and functional result
[8]. The factors responsible for the development of a chronic
wound remain unclear, however the most common cause,
according to Mathieu [9], is thought to be related to the
detrimental effects of prolonged wound hypoxia (oxygen deficien-
cy). Enoch et al. reports that chronic wounds can be arrested in
any one of the stages of wound healing, but disruption commonly
occurs in the inflammatory or proliferative phases [4].
HBOT involves the intermittent exposure of the body to 100%
oxygen at a pressure greater than 1 atmosphere (atm) and its use is
supported in the treatment of problem wounds [10]. However,
there is much debate about the optimal HBOT protocol in
treating such wounds [11–14]. Although HBOT is typically used
as an adjunctive therapy for treating chronic wounds, many
clinicians lack a full knowledge of the evidence-based data that
support its use [15].
The primary rationale behind the use of HBOT in the
treatment of chronic wounds is to elevate the amount of oxygen
delivered to the wound site [16]. For a more detailed review of the
wound healing process, the different etiologies of chronic wounds
and the use of HBOT to treat nonhealing wounds see Thackham
et al. [5]. It should be noted that HBOT is not the only wound
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use of topical oxygen therapy to assist the closure of chronic
wounds [17].
While the wound healing process is undeniably complex, there
are useful mathematical models that address various aspects of the
phenomenon. The models can be categorised into four broad
groups: continuum reaction-diffusion models, mechanochemical
models, discrete/stochastic models and multiscale models.
Discrete models have the ability to contain a level of detail that
is not possible from a continuum model and, in general, allow for
quicker numerical simulation however, continuum models allow
mathematical analysis that discrete models do not.
Continuum reaction-diffusion models are arguably the most
commonly used theoretical approach for studying the angiogenesis
process. One of the first models of this kind is due to Balding and
McElwain, who developed a model to investigate tumour-induced
angiogenesis[18]. Theirmodel consisted ofdistinct equationsforthe
blood vessel and capillary tip density. Edelstein had previously used
a similar approach to model fungal growth [19]. The concept
behind including both blood vessel and tip species is that the ECs in
the tip of a vessel guide the ECs in the sprout. This aspect of the
model, the so-called ‘‘snail-trail’’ production of blood vessels, means
that if the capillary tip density, n, moves with a velocity v,t h e nt h e
rate of increase (that is, production/extension) of blood vessels is
given by (nv):^ v, where ^ v is a unit vector in the direction of v.T h e
model by Balding and McElwain accounts for branching and
anastomosis but does not accountfor the extensionofvascularloops.
In 1996, Pettet and coworkers developed two models of wound
healing angiogenesis [20,21]. Sherratt, in 2002, described the work
in [21] as ‘‘the most important theoretical work on wound
angiogenesis to date’’. In [20] Pettet et al. proposed a three species
simplification of the more detailed six species model of wound
healing angiogenesis presented in [21] and used an analytic
approach to obtain an approximate solution. The first and
foremost feature of these models is that they incorporate the
dependence of chemoattractant production on the local wound
oxygen concentration, with chemoattractant production occurring
in a specific oxygen concentration range. Both of these
publications modelled the extension of blood vessels using the
Balding and McElwain ‘‘snail-trail’’ concept. Other authors have
chosen this approach to model wound and tumour angiogenesis
(see for example [7,22,23]).
In 2002, Gaffney et al. used a two-species model to investigate
cutaneous wound healing [24]. Here a travelling wave analysis was
used to identify a lower bound on the wave speed of the wound
healing unit in terms of two key model parameters, namely, the
random motility of capillary tips and the rate of budding of tips.
Importantly, Gaffney et al. chose not to use a snail-trail approach,
opting rather to consider the EC density explicitly in addition to
the capillary tip density [24]. The flux of the capillary tips is
determined by random motion and directed motion. The flux of
the EC is then assumed to be proportional to the tip flux, where
the rate constant is the number of EC that makes up an average
capillary tip. More recently, Schugart et al. developed a seven
species model of acute wound healing angiogenesis [25], using a
similar approach to Gaffney et al. [24] in their treatment of the EC
flux, while Addison-Smith et al. used a simple mechanistic model
for the sprouting of vessels during tumour-induced angiogenesis
[26]. Mantzaris et al. provides an excellent review of continuum
models of angiogenesis and concludes that continuum models are
important for providing significant insight into the relative
importance of different processes [27].
The interactions between cells and the substratum in wound
healing are not just chemical; there is also a mechanical influence
[27]. For instance, in order to migrate, ECs extend lamellipodia in
the direction of migration, and exert tractional forces on the ECM.
Mechanochemical models of wound healing are essentially
continuum models that account for the forces that cells exert on
the ECM. Mechanochemical models of wound healing include the
early work by Tranquillo and Murray [28–30] and the extensions
by Olsen et al. and Cook [31,32]. These models consider the
connection of cells to the ECM and are thus relevant for deeper,
dermal wounds. They are typically applied to acute (normal)
healing wounds that heal primarily by contraction.
Mechanochemical modelling is needed when considering the
remodelling phase of wound healing since it is during this stage that
the wound contracts. However, since we are interested in chronic
wound healing, and chronic wounds typically arise due to
complications in the inflammatory or proliferative phase, the use
of mechanochemical models is not addressed here. Furthermore,
healing in human wounds is predominantly due to proliferation and
migration of cells from outside the wound, whereas in animal
models, the contraction of the wound by mechanical forces is
thought to be more substantial. It is interesting to note that whilethe
critical role of oxygen in wound healing is well known there are no
mechanochemical models, to date, that incorporate angiogenesis.
Discrete models, using cellular automata for example, have
been used to capture key features of angiogenesis including the
outgrowth, branching and anastomosis of vessels. Stokes and
Lauffenburger pioneered the discrete modelling of blood vessel
formation in their series of publications [33–35]. Their work is
discrete in that they present a stochastic model for the random
motility and chemotaxis of individual cells. Other aspects of their
model use continuum modelling, for example, in the conservation
equation for the chemoattractant. Levine and coworkers extended
this approach with a series of publications [36–40] in which they
investigated the mathematical modelling of tumour-induced
angiogenesis. In these models, continuous limits of reinforced
random walk equations govern the angiogenesis process while
ordinary differential equations (ODEs) model the biochemical
kinetic equations. In their review, Mantzaris et al. states that one
main advantage of using discrete models rather than continuum
ones is that individual cells and sprouting of vessels can be tracked
Author Summary
In the time it takes you to read this paragraph, one person
will have undergone a lower limb amputation due to
diabetic foot disease. With the global diabetes population
on the rise and set to reach 330 million by 2025, the need
for research into therapies and technologies that have the
potential to prevent amputation is dire. There is much
debate about the best way to treat these wounds, and one
treatment that is shrouded with controversy is Hyperbaric
Oxygen Therapy (HBOT). There are currently no conclusive
data showing that HBOT can assist chronic wound healing,
but there has been some clinical success. In light of how
expensive properly designed clinical trials can be, we must
turn to alternative methods of assessment, such as the
theoretical model presented here. The mathematical
model reproduces a number of clinical observations. A
key result is that while HBOT can assist chronic diabetic
wounds, it holds little benefit for wounds that would heal
of their own accord. This model represents a useful tool to
analyse the optimal protocol, and the results and insights
gained from the model may be used to improve both the
success rate and thus the cost-effectiveness of this
therapy.
Model of HBOT Applied to Chronic Wounds
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efficient, and provide quantitative numerical data, these models
are not as readily amenable to mathematical analysis as
continuum models are.
Multiscale techniques have been used to simulate the wound
healing process (see for example Dallon et al. and Cai et al.
[41,42]). Sun et al. have developed several models of angiogenesis
including a multiscale model where the concentration of
chemoattractant is modelled at the tissue scale, while the capillary
network is modelled at the cellular scale [43,44]. More recently,
Alarcon and coworkers and McDougall and coworkers have used
multiscale techniques to investigate angiogenesis associated with
tumour growth [45–48].
The overall aim of this paper is to use a theoretical model to
evaluate the use of hyperbaric oxygen therapy as an adjunct
therapy (a therapy used to assist a primary treatment) for treating
chronic wounds. Through numerical simulations we conclude that
intermittent hyperbaric oxygen therapy has the potential to aid in
the healing of chronic wounds (a chronic wound is one which does
not heal in an orderly set of stages and in a reasonable amount of
time in the way that most wounds do).
Results
We use the model presented in the Materials and Methods
section to simulate a number of different wound healing scenarios,
each of which is discussed below.
Normal Wound without HBOT Exposure
Wesimulate an acute healing wound with the choice of parameters
outlined in Table 1, noting that this choice of values yields a steady
state oxygen concentration behind the wave front (behind the healing
front the oxygen concentration, w,tend stok2b0=2k4 as t??)a b o v e
the lower threshold for capillary tip production, wL,s ot h a th e a l i n g
will be initiated. Fig 1 shows such a normal situation in which a
wound of length 2 cm (that is, L~1) is almost completely
reoxygenated within 2 weeks. It would take longer than this, roughly
2.5 weeks, for the simulated wound to completely revascularise. We
note that the vessel density can rise above the carrying capacity, b0,
due to rapid chemotaxis and may remain elevated until the
remodelling process drives the density to return to normal levels.
Chronic, Stalled Wound without HBOT Exposure
A chronic wound is simulated by selecting parameter values such
that the oxygen concentration behind the injured tissue (near x~0
the oxygen concentration tends to k2b0=2k4) does not rise above the
lower threshold for capillary tip production, wL. As mentioned
above, ourassumptionis that chronicity is associated with a reduced
or impeded supply of oxygen from the vasculature. We therefore
reduce the value of k2 used for the simulation in Fig 1 by a factor of
10 to k2~0:104. The resulting simulation produces an oxygen
profile thatisalwayswithinthe range ½0,wL  (thatis,below the lower
threshold for capillary tip production) inside the wound. Fig 2 shows
the chronic wound simulation. We note no significant change over
time, indicating that no healing is taking place.
Table 1. Parameter values.
Parameter Value Units References
L 1 cm Our choice
Dw 0.18 cm
2/day [74,75]
w0 100 mmHg [76]
b0 250 vessels/cm [76]
k2 1.04 mmHg/vessel/day Calculated based on w0 value
k3 1.3 /day [35]
k4 1.3 ml O2/ml tissue/day [78]
a 20 dimensionless [77]
x 0.01 cm
2/day/mmHg Our choice
k5 28.8 /cm/day [80]
k6 28.8 /cm [24,80]
wL 10 mmHg [81]
wH 35 mmHg [81]
w1 5 mmHg Our choice
e 0.1 cm Our choice
A summary of the parameter values used to simulate successful wound healing.
doi:10.1371/journal.pcbi.1000451.t001
Figure 1. Simulation of successful wound healing. Parameter
values for this simulation are shown in Table 1, except here a~0.
Multiple day intervals are shown (dark blue=2, red=4, green=6,
black=8, yellow=10, light blue=12, pink=14). The top graph shows
oxygen tension (mmHg), the middle graph shows tip density
(capillaries/cm
2) and the bottom graph shows blood vessel density
(vessels/cm).
doi:10.1371/journal.pcbi.1000451.g001
Figure 2. Simulation of a chronic wound in which no healing
occurs. Multiple day intervals are shown (dark blue=2, red=4,
green=6, black=8, yellow=10, light blue=12, pink=14). Parameter
values: as per Fig 1, except k2~0:104.
doi:10.1371/journal.pcbi.1000451.g002
Model of HBOT Applied to Chronic Wounds
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We now investigate the impact of HBOT on the healing of a
chronic wound. The strength and duration of HBOT are given by
the parameters a and t0 in the model, respectively. The parameter
a is a measure of the relative increase in supply of oxygen during
HBOT compared to times of no treatment. Fig 3 shows such a
chronic wound situation under HBOT with a~20 for t0~1:5
hours per day (that is,
1:5
24
of a day). A value of a~20 is associated
with 100% oxygen at a pressure of just under 3atm (see Materials
and Methods Section), which is a reasonable treatment protocol.
We note from the simulation that the capillary tip density in the
chronic wound reaches highly elevated levels under treament and
that healing is quickly initiated in the chronic wound.
Chronic Wound with Insufficient and Excessive HBOT
Exposure
Table 2 shows that an a value of 5.73 equates to 100% oxygen
at 1atm (that is, normobaric oxygen therapy). The analysis
presented later (see Expression (22) in ‘‘Analysis of Feasible HBOT
Protocol’’) predicts that a chronic wound simulated with a~5:73
will not heal and this is confirmed by numerical simulations. Thus
we have shown, under the assumptions on the model presented
here, that normobaric oxygen will not stimulate healing of a
chronic wound and we have answered the somewhat controversial
question of whether or not normobaric oxygen can be used to
substitute for HBOT in the treatment of chronic wounds.
Normobaric oxygen fails to stimulate healing in the chronic
wound since the oxygen levels under the treatment are still
insufficent to initiate capillary tip production. Similarly, our
numerical simulations reveal that values of a in excess of about
2000 are too high to enable healing to occur. This is because the
oxygen levels are raised so much under the treatment that
capillary tip production is switched off when the upper oxygen
threshold, wH, is reached and surpassed. Such high values of a are
not considered physically feasible (see Table 2).
Chronic Wound with Premature Termination of HBOT
The results presented in Fig 4 reveal what happens when we
simulate a situation in which HBOT is halted prematurely (after 5
days). Interestingly, the effects of HBOT seemed to persist for
some time after treatment is halted, but the healing progress slows
considerably (compare Figs 3 and 4). Thus, if we want the wound to
close as quickly as possible, then HBOT should not be terminated
until complete healing of the wound is observed. Note that this is in
disagreement with typical clinical protocols, which is to apply the
therapy daily for about 6 weeks [16]. This restriction is likely based
on cost considerations rather than clinical or experimental evidence
which indicatesthat thisis more effective instimulating healing than
continuing until the wound is completely healed.
Normal Wound with HBOT Exposure
Many hyperbaric centers around the world advocate the use of
HBOT to treat ‘normal’ wounds on the basis that HBOT may
accelerate healing in sports injuries [49]. This use of HBOT is highly
controversial [50]. Typically a sports injury is internal (muscular)
rather than dermal, but here we consider the effect of applying
HBOT to a normal healing wound. Comparing Figs 1 and 5, we see
that there is little benefit (at most, a 10% increase in the rate at which
blood vessels are progressing through the wound space) in applying
HBOT to a wound that progresses through the healing process of its
own accord. Furthermore, the relatively high-cost of HBOT further
detracts from the appeal of its use to treat such wounds. This
simulation also shows that the capillary tip density falls significantly
towards the end of the healing process. Numerical experimentation
reveals that healing will occur, even with very small levels of capillary
tips, suggestingthatit is the presence of capillarytips, rather than their
quantity, that is important for initiating healing. Clinically, this means
that stimulating capillary tip production is the crucial factor that
enables a chronic wound to heal when HBOT is applied.
We note from Fig 1 and 5 that the density of capillary tips at
comparable times is lower in the treated wound than the untreated
one. This result can be explained as follows. The normal wound
develops a vasculature which supplies sufficient oxygen to the
wound to initiate angiogenesis. The wound does not require
HBOT to heal. The application of HBOT to this wound increases
oxygen levels and reduces the net tip production during times of
Figure 3. Simulation of the treatment of a chronic wound with
HBOT for 1.5 hours per day. Multiple day intervals are shown (dark
b l u e = 2 ,r e d = 4 ,g r e e n = 6 ,b l a c k = 8 ,y e l l o w = 1 0 ,l i g h tb l u e = 1 2 ,
pink=14). Parameter values: as per Fig 2, except a~20.
doi:10.1371/journal.pcbi.1000451.g003
Table 2. Typical Protocols.
Pressure Oxygen PAO2 PAO2 Calculated a
(atm) level calculated clinical  wHBOT= w w
1 21% 100 89 1 0
1 100% 673 507 6.73 5.73
2 100% 1433 N.A. 14.33 13.33
2.4 100% 1737 N.A. 17.37 16.37
3 100% 2193 1721 21.93 20.93
A summary of values for the parameter a for some typical protocols.
doi:10.1371/journal.pcbi.1000451.t002
Model of HBOT Applied to Chronic Wounds
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preceding paragraph, we deemed the therapy to have a positive
effect on healing however, this was based on the faster progression
of blood vessels through the wound site under the treatment.
Clinical Implications of Feasible HBOT Protocol Region
We now discuss the potential clinical implications of the
restrictions derived for the HBOT protocol, the mathematical
detail of which is shown in ‘‘Analysis of Feasible HBOT Protocol’’
in ‘‘Materials and Methods’’. By considering the feasible HBOT
protocol (that is, the range of a values, where a is the relative
increase in supply of oxygen during HBOT) to be those that
1. allow the oxygen concentration at the wound edge to rise
above wL after one session and
2. allow the oxygen concentration at the wound center to fall
below wH before the start of the next session
where wL and wH are the lower and upper oxygen concentration
thresholds, respectively, for capillary tip production to take place,
we are able to derive constraints that depend on key parameter
values from the model for the range of feasible HBOT regimes.
We note that if a lower bound is too high then a patient would
need to be exposed to levels of pressure that are not safe in order
for healing to be observed. For instance, if a particular set of
wound parameter values lead to a lower bound that exceeds
twenty-one, then we must conclude that HBOT will not assist this
patient, since only av20:93 is clinically reasonable (see Table 2).
We consider two approaches to estimating the feasible protocol
region. The first approach is to assume that the kinetics dominate the
evolution of the oxygen concentration within the wound space and the
second is to assume that the blood vessels do not migrate into the
wound significantly over the first 24 hours of healing and to solve the
resulting partial differential equation (PDE) for the oxygen concen-
tration using Green’s functions. We will not consider the upper bound
from either approach since both failed to yield clinically relevant
restrictions. Instead we focus on the two lower bounds, namely:
a1,low~
2k4 wL{w1e{k4=8   
k2b0(1ze{k4=8)
{1 ð1aÞ
and
a2,low~
wL{w1e{3k4=24 e
Lz 2
p
P ?
n~1
1
nsin npe
L
  
exp {Dwn2p2
L2
hi
1:5
24
     
k2b0e
2k4L 1{e{3k4=24 ðÞ z 2k2b0
p
P ?
n~1
sin npe
L ðÞ
nbn 1{e{1:5bn=24 ðÞ
{1 ð1bÞ
where bn~2k4zDwn2p2=L2 and a1,low and a2,low are the lower
bounds for the first and second approach, respectively, described
above.
We use Eqs (1a) and (1b) to identify patients who are unlikely to
benefitfromHBOT:theseindividualswillhavehighervaluesofa1,low
and a2,low. Examining Eqs (1a) and (1b) reveals that patients with the
following characteristics are unlikely to benefit from HBOT:
N poor arterial supply of oxygen (reduced k2). This includes
patients that suffer from diseases that lead to vasoconstriction
(such as peripheral arterial disease [51] that results in a
narrowing of the arteries). Furthermore, patients with sepsis
and/or adult respiratory distress syndrome often have
abnormalities in oxygen delivery throughout the body [49].
N a high removal of oxygen from the wound tissue (increased k4).
This includes patients with increased levels of bacteria in their
wounds, since a high bacterial load is known to increase the
consumption of oxygen within the wound space substantially
[52].
N excessively hypoxic wounds (reduced w1). The more hypoxic
the wound is when the patient first arrives for treatment, the
harder it will be for the wound to reach the conditions needed
for capillary tip production and hence successful healing.
Chronic wound hypoxia is known to blunt antibacterial
activity, collagen synthesis and neovascularization [53].
N dysfunctional EC response to oxygen (higher wL). A patient is
unlikely to respond to HBOT if their wound inflammatory
cells (such as macrophages, fibroblasts and ECs) respond
inappropriately to the local level of oxygen. Diseases such as
venous hypertension cause veins to become congested with
different matrix molecules and locks the wound into a self-
amplifying stage of chronic inflammation [54]. In this instance,
cells such as fibroblasts loose their ability to respond to
chemical stimuli. Similarly, if ECs loose their ability to respond
appropriately to oxygen within the wound, then there is a risk
of non-responsiveness to HBOT.
Figure 4. Simulation of the treatment of a chronic wound with
HBOT for 1.5 hours per day, where the treatment is stopped
after 5 days. Multiple day intervals are shown (dark blue=2, red=4,
green=6, black=8, yellow=10, light blue=12, pink=14). Parameter
values: as per Fig 2, except a~20.
doi:10.1371/journal.pcbi.1000451.g004
Figure 5. Simulation of a normal wound under HBOT. Multiple
day intervals are shown (dark blue=2, red=4, green=6, black=8,
yellow=10, light blue=12, pink=14). Parameter values for this
simulation are the same as in Fig 1, except a~20.
doi:10.1371/journal.pcbi.1000451.g005
Model of HBOT Applied to Chronic Wounds
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In this paper we have developed a simple mathematical model
that simulates the healing of both acute and chronic wounds. The
modelling framework is based on the premise that chronic wound
healing is associated with poor and/or impeded oxygen delivery
from the vasculature. We are now in a position to extend the
model to investigate other hypotheses. For example, chronic
wound healing may be associated with impaired cellular function
such as poor cell chemotactic responsiveness [55]. Alternatively,
certain chronic wounds may be extremely hypoxic because there is
a high bacterial load in the wound bed [56]. Our model can easily
be adapted to study this situation by increasing k4, the rate of
removal/consumption of oxygen in the equation governing the
oxygen distribution, Eq (2a).
The development of new blood vessels occurs by two processes,
namely, angiogenesis and vasculogenesis. Here we have only
modeled the effect of oxygen on angiogenesis. The extension of the
model to include the vasulogenesis and its potential as a
mechanism for the improved healing associated with HBOT is a
further extension of the model. There has already been some work
on the role of vasculogenesis in tumour growth (see for example
Stamper et al. [57]).
We used our model to evaluate the effect of treating chronic
wounds with HBOT. In summary, our simulations have allowed
us to make several, clinically-relevant conclusions including the
following:
N intermittent HBOT accelerates the rate of healing of a chronic
wound;
N normobaric oxygen therapy can not be used as a substitute for
HBOT;
N treatment of a chronic wound with HBOT should not be
stopped prematurely but continued until healing is complete.
While there is much debate about how many sessions of
HBOT should be administered, it has been observed that
premature discontinuation of the therapy can have negative or
even tragic consequences for the patient [58];
N healing of a chronic wound can occur under HBOT even with
very small quantities of capillary tips present, indicating that it
is their presence that initiates healing;
N identifying the range of clinically useful HBOT protocols (that
is, protocols that stimulate healing) is crucial if HBOT is to
enhance the healing process.
By considering the feasible HBOT protocol (that is, the range of
a values, where a is the relative increase in supply of oxygen
during HBOT) to be those that
1. allow the oxygen concentration at the wound edge to rise
above wL after one session and
2. allow the oxygen concentration at the wound center to fall
below wH before the start of the next session
where wL and wH are the lower and upper oxygen concentration
thresholds, respectively, for capillary tip production to take place,
we were able to derive constraints that depend on key parameter
values from the model for the range of feasible HBOT regimes. By
considering patients that will need excessive exposure to pressure in
order to stimulate healing in conjunction with the lower bounds on
the a parameter, we predict that patients with any of the following
conditions are unlikely to respond well to HBOT:
N poor arterial supply of oxygen,
N high removal of oxygen from the wound tissue,
N excessively hypoxic wounds and
N dysfunctional EC response to oxygen.
In conclusion, we have used a simple three species model of
wound healing to evaluate the effect of treating chronic wounds
with HBOT. While the causal reasons for the improved healing
remain unclear, protocols will remain empirical and an
unreliable screening process for appropriate patients will
remain in place. The work of this paper is a first step towards
identifying in a systematic manner patients who are likely to
respond well to HBOT and thus has the potential to assist in
improving both the success rate and the cost-effectiveness of this
therapy.
Materials and Methods
We adopt a continuum approach to modelling angiogenesis in
wound healing, similar to that of Balding and McElwain [18]. We
focus on three key species: oxygen: w, capillary tips: n and blood
vessels: b. For simplicity, we consider the wound to be one-
dimensional, of total length 2L and symmetric about its centre.
Here x~L represents the wound centre while x~0 denotes the
edge of the wound. Equations governing the evolution of w, n and
b are presented in turn below.
Oxygen concentration, w(x,t):
Lw
Lt
~Dw
L
2w
Lx2
diffusion
z k2b(1za)
supply via blood
vessels
{k4w 1z
b
b0
  
decay and removal
via blood vessels
: ð2aÞ
That diffusion is the primary mechanism by which oxygen is
transported through an unvascularised wound site is well
established [59] and here we assume a linear diffusion equation
for oxygen, with assumed constant diffusivity Dw. Clearly the
formation of new blood vessels to replace the damaged system
will increase the supply of oxygen (and other nutrients) to the
wound site [51]. We assume that oxygen is supplied by new
vessels at rate k2.W ea s s u m et h a to x y g e ni sr e m o v e dv i at h e
vasculature at rate k4. Molecular oxygen is also assumed to decay
naturally. HBOT is known to substantially increase oxygen levels
within the wound [5,60] and we thus model the application of
HBOT to a wound as an increase in supply during the time of
treatment. That is, we take aw0 during the session and 0 at all
other times.
Capillary Tip density, n(x,t):
Ln
Lt
~x
L
Lx
n
Lw
Lx
  
chemotaxis
zk5bH(w{wL)H(wH{w)
sprouting from existing vessels
{ k6n
anastomosis
(and tip death)
,ð2bÞ
where H(:) is the Heaviside function. We assume that the
dominant mechanism for capillary tip movement is migration
down the oxygen gradient (with coefficient x). That is, the tips are
attracted to regions of relative hypoxia, which is consistent with
the experimental literature [61]. We note that, typically chemo-
taxis is used to model attraction of a species towards a chemical
gradient, whereas we are using it here to model the migration of
capillary tips down the oxygen gradient and thus the term appears
slightly differently than a typical chemotaxis term. Tip sprouting
occurs from existing vessels at rate k5 within a range of values of
oxygen concentration, wLvwvwH. This reflects the well-
established concept that proliferation of the ECs that constitute
Model of HBOT Applied to Chronic Wounds
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Capillary tips are known to be lost due to anastomosis during the
healing process [63] and here we model this as a linear process
with rate constant k6.
The idea that the oxygen gradient within the wound tissue is
responsible for driving the process of angiogenesis is well-
supported in the literature [2,11,61,64–66]. For instance,
Tompach et al. states that ‘‘angiogenesis is driven by a gradient
of oxygen whereby high arterial oxygen tension drives angiogen-
esis into hypoxic spaces’’ [11] while Oberringer et al. make note
that ‘‘the oxygen gradient serves as a key stimulus for the direction
of cell migration’’ [61]. While we acknowledge that a gradient of
chemoattactant (such as vascular endothelial growth factor
(VEGF)) may also be present in the wound, we justify modelling
the oxygen concentration as a chemical stimulus without including
VEGF by referring to the statement by Bao et al. ‘‘a gradient of
VEGF expression is established that parallels the hypoxic gradient,
and ECs subsequently migrate toward the most hypoxic areas’’
[67].
There is evidence that oxygen regulates the production of
chemoattractant by macrophages and that it is the stimulus
provided by the chemoattractants that stimulate angiogenesis [68–
71]. Pettet et al. avoid the inclusion of a macrophage species in
their model by assuming that within a window of oxygen
wLvwvwH, chemoattractants are produced, which in turn
stimulate new blood vessel production. Here we avoid the need
for explicitly including the chemoattractant by assuming that
capillary tips are produced only within the oxygen interval
wLvwvwH. This is consistent with current literature suggesting
that in both chronically hypoxic wounds [72] and those that have
high levels of oxygen [68], angiogenesis is halted.
Blood vessel density, b(x,t):
Lb
Lt
~{xn
Lw
Lx
snail trail
production
zk3b 1{
b
b0
  
remodelling
: ð2cÞ
We apply the widely used Balding-McElwain ‘‘snail trail’’
approach to modelling the laying down of blood vessels by the
moving capillary tips [18,27]. After the rapid formation of blood
vessels during the inflammatory and proliferative stages of healing,
the vasculature system is remodelled [73] and we assume that this
behaviour can be described by a logistic term with growth rate k3
and the normal blood vessel density, b0, as the ‘‘carrying
capacity’’.
In order to close Eqs (2a)–(2c), we impose boundary and initial
conditions as follows. At the wound centre, x~L, we impose zero
flux of oxygen due to the assumed symmetry of the wound about
x~L, so that:
Lw
Lx
       
x~L
~0: ð3aÞ
We assume that the wound edge is devoid of capillary tips and
that the flux of oxygen there is zero so that the wound and tissue
oxygen concentrations rapidly equilibrate under intermittent
HBOT and we have
Lw
Lx
       
x~0
~0, ð3bÞ
and
n(0,t)~0: ð3cÞ
We assume that initially the wound is devoid of tips, the blood
vessel density is that of normal tissue within a certain area of the
wound edge (0vxve) and the wound is partially oxygenated
throughout this vascularised region so that
w(x,0)~
w1 0vxve
0 evxƒL,
 
ð3dÞ
b(x,0)~
b0 0vxve
0 evxƒL,
 
ð3eÞ
n(x,0)~0,0ƒxƒL: ð3fÞ
For numerical simulations, the discontinuity in the initial
condition of the blood vessels is ‘‘smoothed’’ by replacing the
two sharp corners with two small quarter-circles.
Parameter Estimation
Wound length, L. We consider a square wound, with sides of
length 2 cm. Due to the assumed symmetry of the wound, this
gives L~1cm.
Diffusion Coefficient for Oxygen in Tissue, Dw. It is
generally agreed that the diffusivity of oxygen in water is
2610
25 cm
2/sec (or, equivalently, 1.728 cm
2/day). Following
Croll et al., the effective diffusivity in a porous medium can be
described by Maxwell’s solution:
Dw
D
~
2(1{e)
2ze
,
where D is the oxygen diffusivity in the extracellular fluid (that is,
water), Dw is the effective diffusivity throughout the porous
medium and e is the volume fraction of intracellular material [74].
Bjornaes et al. claims that the extracellular volume fraction is
approximately 0.15 for tumour tissue [75]. Fixing e~0:85 and
D~1:728cm2 
day we estimate Dw~0:18cm2 
day.
Characteristic oxygen concentration, w0. Secomb et al.
argues that the average oxygen tension at the entrance of the
capillaries is 100 mmHg [76]. This is consistent with estimates
from other authors including Piantadosi [77]. We therefore fix
w0~100mmHg.
Rate of removal of oxygen from the wound,
k4. Takahashi et al. calculates an oxygen consumption rate of
k4~1:3m lof oxygen per ml of tissue per day which we use in our
simulations [78]. We do acknowledge, however, that oxygen
consumption rates reported in the literature vary widely.
Characteristic vessel density, b0. Secomb et al. states that
the capillary density is in the range of 4.68–10610
4 capillaries/
cm
2 [76]. Assuming that the capillaries are distributed both
homogeneously and isotropically, one can assume that, given x
capillaries per cm
2, a one dimensional cross section of these
capillaries will contain approximately
ﬃﬃﬃ
x
p
capillaries per cm. This
gives the number of vessels per cm to be in the range of 216–316.
Accordingly we fix b0~250.
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by assuming that the spatially homogeneous steady state for
oxygen is identical to the characteristic concentration, w0. This
gives (from Eq (2a)): w0~
k2b0
2k4
, so that k2~1:04 ml of oxygen per
ml of tissue mmHg oxygen/vessel/day.
Relative increase in supply of oxygen during HBOT,
a. Heyneman et al. states that the oxygen tension in hypoxic
wounds is increased from about 10 mmHg to 200 mmHg under
HBOT [79]. This indicates that a&20 for a standard HBO
protocol.
To justify our estimate of the augmented supply of oxygen
during HBOT, a, we use a modelling approach that is supported
by clinical observations. The (calculated mean) alveolar oxygen
tension (PAO2) is given by Piantadosi as:
PAO2~FIO2(Pb{PH2O){PACO2 FIO2z
1{FIO2
R
  
, ð4Þ
where FIO2 is the inspired oxygen level as a percentage of the total gas,
Pb is the barometric pressure (1atm=760 mmHg), PH2O is the water
vapour pressure (47 mmHg at 37uC), PACO2 is the mean alveolar
carbon dioxide tension (40 mmHg) and R is the respiratory quotient
(0.8 when breathing air and 1.0 when breathing 100% oxygen) [66].
Note that Eq (12) is not an empirical formula, rather it is based on the
use of an ideal gas law. This formula predicts that if a patient is
breathing 21% oxygen at 1atm then the alveolar oxygen tension is
PAO2 ~0:21(760{47){40 0:21z(1{0:21)=0:8 ½  &100mmHg.
This is taken to be the base level of oxygen in the arteries surrounding
the wound in the absence of HBO administration (note that the
alveolar and arterial oxygen tensions are comparable [77]). The
parameter a is then assumed to be the ratio of the arterial oxygen
tension under HBOT administration to the baseline level.
We now consider the effect that HBOT has on the spatially
uniform steady state of oxygen (see Eq (2a)):
 w w~
k2b0
2k4
and  w wHBOT~
k2b0(1za)
2k4
ð5Þ
where  w w and  w wHBOT are, respectively, the steady state concentra-
tions in the absence and presence of HBOT, b0 is the blood vessel
density steady state, k2 is the rate of supply of oxygen via the
vasculature and k4 is the rate at which oxygen is removed from the
wound site. The relative increase in oxygen tension, predicted by
the model, is thus  w wHBOT= w w~1za, so that the parameter a is
given by a~ w wHBOT= w w{1. The relative increase in oxygen levels
from normal conditions to HBOT is given by ratio of the PAO2
under the HBOT protocol (calculated from Eq (4)) to the PAO2
under no HBOT (100 mmHg). Estimates of a for a variety of
protocols are shown in Table 2.
We remark that in existing mathematical models no attempt has
been made to base the relative increase of oxygen on either clinical
observations or theoretical arguments. For example, Schugart et
al. arbitrarily increase the oxygen concentration to 2, 3 and 4
times the normalised levels [25].
Rate of sprouting of capillary tips, k5. Stokes et al. used
data from Sholley et al. to estimate a branching rate of 0.12610/
mm/hour [35,80]. This corresponds to k5~28:8=cm=day.
Rate of capillary tip anastomosis, k6. The rate of
anastomosis is difficult to estimate. Gaffney et al. argues that it
should be of the same order of magnitude as the branching rate so
that:
Lk5
k6
~O(1):
Following Gaffney et al. we therefore take k6~28:8=cm [24].
Oxygen window of chemoattractant production,
½wL,wH . While oxygen is known to regulate the production of
angiogenic factors within the wound site [69], there is minimal
quantitative data that can be used to estimate the values of wL and
wH. The centre of a normal healing wound is thought to be
hypoxic with oxygen tensions of about 25 mmHg [81]. We assume
that the window of capillary tip production includes this oxygen
concentration. Furthermore, according to Albina et al., maximal
hypoxia (of about 10 mmHg) occurs about 4 days post injury [82].
Guided by these data we fix ½wL,wH ~ 10mmHg, 35mmHg ½  .
Initial oxygen concentration in vascularised region,
w1. For a chronic wound, we require w1vwL since if w1wwL
thensometipproductionoccursandhealingisinitiatedimmediately.
With wL ~ 10mmHg, we therefore fix w1~5mmHg.
Rate of remodelling of blood vessels, k3. The rate at
which the blood vessels are remodelled is also difficult to estimate.
Following Gaffney et al., we assume that vessel production is
ultimately driven by EC proliferation [24]. The EC proliferation
rate was estimated by Stokes et al. to be approximately 0.056/
hour [35]. Assuming that vessel production is dominated by EC
proliferation and using the above estimate of EC proliferation we
arrive at k3~1:3=day. In our simulations, we therefore fix
k3~1:3=day, which is in line with Gaffney et al. and Stokes et al.
[24,35].
Chemotactic responsiveness of capillary tips to oxygen
gradient, x. It is difficult to estimate the chemotactic
responsiveness of the capillaries to the hypoxic gradient, since, to
our knowledge, there is no experimental data available on the
migration rate of ECs in various oxygen gradients. Stokes et al.
found that the chemotactic responsiveness of EC to a spatial
gradient was approximately x 2600 cm
2/sec/M at a chemical
concentration of a0~10{10M [33]. From this value, we estimate
the chemotactic responsiveness of ECs to an oxygen gradient.
Typical oxygen concentrations within the wound (that is, w0) are
100 mmHg. The chemotactic coefficient for fibroblast growth
factor (FGF) reported by Stokes et al. is crudely converted to a
responsiveness of the EC to an hypoxic gradient by:
xa0=w0:
This gives 2.2610
24 cm
2/day/mmHg. Numerical simulations
reveal that a 2 cm wound with this chemotactic responsiveness will
take many months to heal. This is not realistic for a normal healing
wound, which should proceed through the inflammation and
proliferation stages of healing within a few weeks [4,5]. In fact,
Lokmic et al. found that the presence of hypoxia in wound tissue
declined after 2 weeks [73]. By using the criterion that the wound
should reestablish oxygen levels, roughly speaking, within 2 weeks,
we fix x~1|10{2cm2 
day=mmHg.
The parameter values for the normal wound simulation are
summarised in Table 1. In a chronic wound, we argue that there
is a general decrease in the rate of supply of oxygen due to
edema, eschar and bacterial load within the wound [83] and
hence that the characteristic oxygen concentration will be
significantly reduced. Heyneman et al. states that the oxygen
tension in hypoxic wounds is around 10 mmHg (compared to
100 mmHg in normal wounds) [79]. We therefore take this to be
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many different causes of chronic wounds including diabetes, arterial
disease and venous insufficiency. Peripheral neuropathy is consid-
ered to be a leading cause in the development of diabetic foot ulcers
[84]. This commonly leads to blood flow abnormalities which can
divertbloodbeforeithasachancetodelivernutrientsand oxygento
the body tissues [85]. We therefore simulate diabetic wound
chronicity by reducing k2, the rate at which the wound is supplied
with oxygen, by a factor of 10 (that is, k2~0:104 for the chronic
simulations). This is the only parameter we change, although we
acknowledge that there may be other parameter changes (or
combination of changes) that could simulate a stalled, nonhealing
wound. The parameters and variables presented here are
dimensional, however the parameter a is dimensionless. It is a
measure of the relative increase in supply of oxygen during HBOT.
Based on both clinical observations and theoretical predictions,
a&20isfoundtobeappropriateforthe simulationspresentedinthe
Results section.
Advection-dominated initial boundary value problems (IBVPs)
arise naturally when developing models of wound healing and in
other areas of biology [7,20,21,86,87]. The numerical method
implemented in the case of advection-dominated IBVP must be
constructed carefully for reasons outlined previously [88]. The
problem presented here is solved using a finite volume method
(FVM) with a Roe flux limiter [89], and all simulations are
performed with 1500 control volumes.
Analysis of Feasible HBOT Protocol
We now determine parameter constraints on the HBOT
protocol by considering the change in oxygen concentration over
the first 24 hours of treatment. Consideration of Eqs (2a)–(2c)
reveals that unless the oxygen concentration somewhere within the
wound space falls in the range ½wL,wH , then production of
capillary tips is not possible and healing will not occur. We thus
define ‘‘feasible’’ a values to be those that
1. allow the oxygen concentration at the wound edge to rise
above wL after one session has been completed and
2. allow the oxygen concentration at the wound center to fall
below wH before the start of the next session.
Current clinical protocol is to administer 1.5 hours of treatment
once per day. Hence the above two conditions can be expressed
mathematically as:
1. w(0,1:5=24)wwL and
2. w(L,1)vwH (Recall that the oxygen concentration, w(x,t),i s
measured at position, x, which is given in centimeters and time,
t, which is given in days.)
We consider two approaches to deriving the aforementioned
constraints. The first involves assuming that the kinetics of Eq (2a)
dominate the oxygen concentration within the wound space. This
allows us to consider a time-dependent ODE for the oxygen
concentration which is solved using standard techniques. The
second approach is to assume that the blood vessels do not migrate
into the wound significantly over the first 24 hours of healing. The
resulting partial differential equation (PDE) for the oxygen
concentration decouples from the remaining equations and can
be solved using Green’s functions [90].
By assuming that the kinetics dominate the evolution of
oxygen within the wound space we arrive at the following ODE
that governs the transition from the steady state oxygen
concentration without HBOT to the steady state concentration
under treatment
d w w
dt
~
k2b(1za){k4w 1z
 b b
b0
  
0vtvt0
k2b{k4w 1z
 b b
b0
  
t0vtv1,
8
> > > <
> > > :
ð6Þ
where t0~1=16, represents the proportion of each day that a
patient is administered HBOT (that is, 90 minutes per day).
From Eq (2a), the blood vessel density at steady state is  b b~b0.
Substituting this into Eq (6) we obtain
d w w
dt
~
k2b0(1za){2k4w 0vtvt0
k2b0{2k4wt 0vtv1,
 
ð7Þ
with w(t~0)~w1.
Eq (7) has solution
 w w~
e{2k4t w1{
k2b0(1za)
2k4
  
z
k2b0(1za)
2k4
0vtvt0
e{2k4t w1{
k2b0(1za{aek4=8)
2k4
  
z
k2b0
2k4
t0vtv1:
8
> > > <
> > > :
ð8Þ
Using Eq (8) it is straight forward to show that our conditions for
the feasible HBOT protocol as outlined previously can be written:
1. e{k4=8 w1{
k2b0(1za)
2k4
  
z
k2b0(1za)
2k4
wwL,
2. e{2k4 w1{
k2b0(1za{aek4=8)
2k4
  
z
k2b0
2k4
vwH.
These inequalities identify a region of a values (that is, HBOT
protocols) for treating a chronic wound such that pro-healing
effects are predicted (under the given assumptions) to be observed:
2k4 wL{w1e{k4=8   
k2b0(1{e{k4=8)
{1vav
2wHk4{k2b0{e{2k4 2w1k4{k2b0 ½ 
k2b0 ek4=8{1 ½  e{2k4 ,ð9Þ
where capillary tip production can only take place in the oxygen
range of ½wL,wH , k4 is the rate at which oxygen is removed from
the wound via the vasculature, b0 is the characteristic blood vessel
density, k2 is the rate at which oxygen is supplied by the blood
vesselsand w1 is the initial oxygen concentrationat the woundedge.
It should be noted that this analysis is based on the assumption
that the wound is chronic in that, if it is left untreated, then the
steady state oxygen concentration will not rise above the lower
threshold for capillary tip production (that is, k2b0=2k4ƒwL).
By substituting the estimated parameter values shown in Table 1
into the inequality in (9), we predict that for this particular set of
parameter values, HBOT will assist healing if:
2:8vav193:6:
Recall that the parameter a is dimensionless. It represents the
increase in supply of oxygen during HBOT relative to periods
without the treatment. It should also be noted that the upper limit
of this region of feasible values is outside what would be considered
‘‘clinically reasonable’’.
Numerical experimentation reveals that a chronic wound
exposed to HBOT with a~7 will not heal, which is in violation
of the inequalities predicted by the above analysis. There are a
number of potential reasons why our lower bound does not
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including:
1. the oxygen kinetics are not dominant and
2. the blood vessel density does not reach steady state levels
during the first day of treatment.
To emphasize the fact that the steady state approach is
inappropriate for deriving the constraints on the feasible HBOT
regime, let us consider a chronic wound exposed to HBOT with
a~20. Fig 6 compares the oxygen concentration at the wound
margin(thatis,atx~0)duringthe firstdayofhealingwiththevalue
predicted from the above steady state analysis. Note from Fig 6 that
the concentration of oxygen at the wound edge differs substantially
from the value associated with the steady state analysis.
On closer inspection Fig 3 reveals that during the first day, the
blood vessels do not migrate deep into the wound. By assuming
that the blood vessel distribution throughout the wound domain
does not change from the initial conditions during the first day of
treatment then the oxygen PDE decouples and we have:
Lw
Lt
~Dw
L
2w
Lx2 zk2b(1za){k4w 1z
b
b0
  
ð10Þ
where b~
b0 0ƒxƒe
0 evxƒL
 
and subject to the boundary conditions
Lw
Lx
       
x~0
~
Lw
Lx
       
x~L
~0. We find the solution to Eq (10) over the first
day of treatment using Green’s functions:
w(x,t)~
ðL
0
f(j)G(x,j,t)djz
ðt
0
ðL
0
w(x)G(x,j,t{t)djdt
where f(x) is the initial distribution of oxygen (see Eq (3d)), b is
given above, w(x)~k2b(1za) and
G(x,j,t)~e
{k4 1z b
b0
  
t 1
L
z
1
L
X ?
n~1
cos
npx
L
  
cos
npj
L
  
exp
{Dwn2p2t
L2
   "#
:
Evaluating the integrals gives:
w(x,t)~w1e{2k4t e
L
z
2
p
X ?
n~1
1
n
cos
npx
L
  
sin
npe
L
  
exp
{Dwn2p2
L2
  
t
   "#
z
k2b0e
2k4L
1za ðÞ 1{e{2k4t   
za e{2k4(t{t0){1
  
H(t{t0)
  
z
2k2b0
p
X ?
n~1
cos npx
L
  
sin npe
L
  
nbn
1za ðÞ 1{e{bnt     
za e{bn(t{t0){1
  
H(t{t0)
 
ð11Þ
where bn~2k4zDwn2p2=L2, t0 is the duration of the HBOT
session on the first day of treatment and H(:) is the Heaviside
function.
By imposing w(0,1:5=24)wwL we find:
aw
wL{w1e{3k4=24 e
Lz 2
p
P ?
n~1
1
nsin npe
L
  
exp {Dwn2p2
L2
hi
1:5
24
     
k2b0e
2k4L 1{e{3k4=24 ðÞ z
2k2b0
p
P ?
n~1
sin npe
L ðÞ
nbn 1{e{1:5bn=24 ðÞ
{1 ð12Þ
and similarly, we can ensure that w(L,1)vwH if a does not
exceed:
wHz e
2L
k2b0
k4 {2w1
hi
e{2k4{ k2b0
k4
  
{ 2
p
P ?
n~1
({1)
n
n sin npe
L
  
e
Le{cnzk2b0
1{e{bn ðÞ
bn
  
k2b0e
2k4L e{2k4(1{1:5=24){e{2k4 ðÞ z
2k2b0
p
P ?
n~1
({1)
nsin npe
L ðÞ
nbn e{bn(1{1:5=24){e{bn ðÞ
ð13Þ
where bn~2k4zDwn2p2=L2 and cn~Dwn2p2=L2. In terms of the
estimated parameter values, shown in Table 1, the region of feasible
a predicted by using Green’s function is given by:
7:5vav4096 ð14Þ
This lower bound is consistent with numerical simulations,
which reveal that healing does not occur with a~7. However, we
Figure 6. Comparison of the full numerical solution (shown in
black) to Eqs (2) and steady state analytic oxygen concentra-
tion (shown in blue) at the edge of the wound, x~0. Parameter
values: as per Table 1 except k2~0:104.
doi:10.1371/journal.pcbi.1000451.g006
Figure 7. Comparison of the full numerical solution (shown in
black) to Eqs (2), the numerical solution to the subproblem
(shown in blue) in Eq (10) and Green’s function analytic oxygen
concentration (see Eq (11)) at the edge of the wound (shown in
dashed black), x~0. Parameter values: as per Fig 6.
doi:10.1371/journal.pcbi.1000451.g007
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considered clinically reasonable.
In Fig 7 we compare the oxygen concentration at the wound
margin during the first day of healing with that predicted using the
Green’s function analysis. We note that there is excellent
agreement between the values obtained by solving the full model
numerically and by using the Green’s function approach.
It should be noted that in practice only the lower bounds
presented here are useful since exposing a patient to high levels of
oxygen for even short periods of time causes oxygen toxicity [91].
In fact, 100% oxygen for 3 hours at 3 atm can cause central
nervous system breakdown [50]. Hence a value of a greater than
20.93 (see Table 2) should be considered clinically irrelevant.
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